UK's drug-cost watchdog recommends use of GSK unit's HIV prevention drug - Reuters

 

The Trump Administration’s Foreign Aid Review: Status of PEPFAR - KFF

 

Ending the HIV Epidemic Initiatives Overlook Gay and Bisexual Latino Men - POZ - Health, Life and HIV

 

US Shouldn't Back Out of Funding HIV Research After Huge Strides Made: Patrick Sullivan, DVM, PhD - The American Journal of Managed Care® (AJMC®)

 

Lenacapavir HIV shot stirs debate in Zimbabwe - DW

 

South Africa welcomes $115M US bridge plan to sustain its HIV programs for 6 months - ABC News - Breaking News, Latest News and Videos

 

German researchers find highly effective HIV antibody - DW

 

South Africa welcomes $115M US bridge plan to sustain its HIV programs for 6 months - WTOP

 

FDA Approves First 1-Minute Self Test for HIV - Drug Topics

 

South Africa welcomes $115M US bridge plan to sustain its HIV programs for 6 months - The Spec

 

South Africa welcomes $115M US bridge plan to sustain its HIV programs for 6 months - ClickOnDetroit

 

South Africa welcomes $115M US bridge plan to sustain its HIV programs for 6 months - AP News

 

US aid cuts deal a massive blow for the small African nation of Lesotho: Takeaways from AP's report - World News - Castanet

 

Charlie Sheen Paid Millions to Keep HIV Status Hidden - Yahoo

 

EACS 2025: Low Risk of HBV Reactivation After Tenofovir Withdrawal in People With HIV - European Medical Journal

 

Fear and worry in Lesotho: Photos show those affected as US aid cuts hit care for HIV patients - Union-Bulletin

 

Fear and worry in Lesotho: Photos show those affected as US aid cuts hit care for HIV patients - AP News

 

HIV rates are highest in the American South, despite effective treatments – a clash between culture and public health - The Conversation

 

Cameroon: A beacon of hope for adolescents and young people living with HIV - WHO | Regional Office for Africa

 

Nigeria accelerating action to expand HIV prevention options with long-acting injectable PrEP - WHO | Regional Office for Africa

 

MSD’s HIV duo non-inferior to SoC in Phase III trials - Clinical Trials Arena

 

EACS 2025: Once-Weekly HIV Pill Maintains Viral Suppression for 96 Weeks - European Medical Journal

 

Pharma Pulse: FDA Approves One-Minute HIV Test, US Delays Pharma Tariffs, and CVS Acquires 600 Rite Aid Stores - Pharmaceutical Commerce

 

Protesters Arrested For Demanding Release of Billions in Life-Saving HIV/AIDS Funding - GO Magazine

 

Five Arrested At Susan Collins' Office - Protesters Demand Release of Billions in Lifesaving HIV/AIDS Funding - GO Magazine

 

Lesotho finds its HIV care system unraveling and patients in despair in the wake of US cuts - The Tri-City Record

 

The tiny African nation of Lesotho had victories in its HIV fight. Then, the US aid cuts came - livingstonenterprise.net

 

Merck Announces New Data from Phase 3 Trials Evaluating the Investigational, Once-Daily, Oral, Two-Drug Regimen of Doravirine/Islatravir (DOR/ISL) in Adults with Virologically Suppressed HIV-1 Infection - BioSpace

 

Fear and worry in Lesotho: Photos show those affected as US aid cuts hit care for HIV patients - The Seattle Times

 

In Lesotho, US aid cuts leave people living with HIV in limbo - AP News